ADRB3 and obesity disorder: These results suggest that WWP1, which is increased in obesity, may reduce catecholamine-stimulated lipolysis in adipocytes via suppression of Adrb3 expression through unknown mechanisms, although these do not seem to involve neurotransmission or NA metabolism.